
Sign up to save your podcasts
Or


This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).
By Mark Ebell4.7
9292 ratings
This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).

134 Listeners

701 Listeners

504 Listeners

298 Listeners

305 Listeners

264 Listeners

3,374 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

251 Listeners

375 Listeners

320 Listeners